Nephropathy in patients with type 2 diabetes

New England Journal of Medicine

Volumn 346, Issue 15, 2002, Pages 1145-1151

  Remuzzi, Giuseppe ^a,c   Schieppati, Arrigo ^a   Ruggenenti, Piero ^b  

^a OSPEDALI RIUNITI   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c MARIO NEGRI INST PHARMACOL RES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; NIFEDIPINE; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CLINICAL PRACTICE; COMORBIDITY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE COURSE; DYSLIPIDEMIA; HUMAN; HYPERTENSION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE; TREATMENT PLANNING; ALBUMINURIA; DRUG COMBINATION; HYPERGLYCEMIA; MIDDLE AGED; PRACTICE GUIDELINE; PROTEIN INTAKE; REVIEW; SMOKING CESSATION;

ALBUMINURIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIETARY PROTEINS; DRUG THERAPY, COMBINATION; HUMANS; HYPERGLYCEMIA; HYPERTENSION; MALE; MIDDLE AGED; PRACTICE GUIDELINES; SMOKING CESSATION;

EID: 0037061867     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMcp011773     Document Type: Article

References (43)

1. Report on management of renal failure in Europe, XXVI, 1995
2. The diagnosis of renal involvement in noninsulin-dependent diabetes mellitus
3. UK Prospective Diabetes Study (UKPDS). IX. Relationships of urinary albumin and N-acetylglucosaminidase to glycaemia and hypertension at diagnosis of type 2 (non-insulin-dependent) diabetes mellitus and after 3 months' diet therapy
4. Nephropathy in patients with type 2 diabetes mellitus
5. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
6. The effect of metabolic control on rate of decline in renal function in insulin-dependent diabetes mellitus with overt diabetic nephropathy
7. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
8. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study
9. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
10. Microalbuminuria, blood pressure and diabetic renal disease: Origin and development of ideas
11. Prévalence et profil d'une atteinte rénovasculaire chez le diabétique de type II hypertendu sévère
12. Comparison of type II and type I diabetics treated for end-stage renal disease in a large prepaid health plan population
13. Preserving renal function in adults with hypertension and diabetes: A consensus approach
14. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy
15. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
16. Evolving strategies for renoprotection: Diabetic nephropathy
17. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
18. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
19. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
20. Renal effects of calcium antagonists in diabetes mellitus: An overview of studies in animal models and in humans
21. Effects of dihydropyridine calcium channel blockers, angiotensin-converting enzyme inhibition and blood pressure control on chronic, nondiabetic nephropathies
22. Effect of ramipril vs. amlodipine on renal outcomes in hypertensive nephrosclerosis: A randomized controlled trial
23. Differential effects of calcium channel blockers on size selectivity of proteinuria in diabetic glomerulopathy
24. Therapeutic efficacy of different antihypertensive drugs in human diabetic nephropathy: An updated metaanalysis
25. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
26. Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy
27. Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: The Candesartan and Lisinopril Microalbuminuria (CALM) study
28. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
29. Effect of lipid reduction on the progression of renal disease: A meta-analysis
30. Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus
31. Effect of dietary protein restriction on prognosis in type 1 diabetic patients with diabetic nephropathy
32. Progression, remission, regression of chronic renal diseases
33. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: The Steno type 2 randomised study
34. Smoking: A factor promoting onset and progression of diabetic nephropathy
35. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance
36. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
37. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
38. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPP) randomised trial
39. Pravastatin and the development of diabetes mellitus: Evidence for a protective effect in the West of Scotland Coronary Prevention Study
40. American Diabetes Association clinical practice recommendations 2001
41. 1998 Clinical practice guidelines for the management of diabetes in Canada
42. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP)